Ablacon, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://ablacon.com
FLOW EVAL-AF: FLOW Mapping Electrogram VALidation in Patients With Persistent Atrial Fibrillation
Not Applicable
Completed
- Conditions
- Longstanding Persistent Atrial FibrillationPersistent Atrial FibrillationAtrial Fibrillation, PersistentArrhythmias, Cardiac
- Interventions
- Device: Electrographic Flow™ Mapping using Ablamap® Software and FIRMap™ Catheter
- First Posted Date
- 2024-02-15
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- Ablacon, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT06260670
- Locations
- 🇩🇪
Herz-und Diabeteszentrum NRW (Clinic of Ruhr University of Bochum), Bad Oeynhausen, North Rhine-Westphalia, Germany
RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.
Not Applicable
Active, not recruiting
- Conditions
- ArrhythmiaAtrial Fibrillation, PersistentAtrial Fibrillation ParoxysmalArrhythmias, CardiacAtrial FibrillationAtrial TachycardiaAtrial FlutterAtrial Fibrillation, Paroxysmal or PersistentAtrial Arrhythmia
- Interventions
- Device: EGF-Mapping of AF Sources (no ablation)Device: EGF-Mapping and EGF-Guided Ablation of AF Sources
- First Posted Date
- 2023-06-01
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- Cortex
- Target Recruit Count
- 400
- Registration Number
- NCT05883631
- Locations
- 🇺🇸
University of Alabama, Birmingham, Alabama, United States
🇺🇸Grandview Medical Center, Birmingham, Alabama, United States
🇺🇸Banner Health, Phoenix, Arizona, United States
AF-FLOW Registry to Evaluate Electrographic Flow Mapping in Patients Undergoing Ablation for Atrial Fibrillation
Completed
- Conditions
- Atrial Fibrillation, PersistentAtrial FibrillationArrhythmias, CardiacHeart Diseases
- Interventions
- Device: Ablamap Software
- First Posted Date
- 2022-08-01
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- Ablacon, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT05481359
- Locations
- 🇺🇸
Piedmont Atlanta Hospital, Atlanta, Georgia, United States
🇳🇱Erasmus MC, Rotterdam, Zuid Holland, Netherlands
🇵🇱Medicover Hospital, Warsaw, Poland
FLOW-AF: A Study to Evaluate Electrographic Flow™ (EGF) Mapping Technology
Not Applicable
Completed
- Conditions
- Atrial Fibrillation, Persistent
- Interventions
- Device: Ablamap Software
- First Posted Date
- 2020-07-16
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- Cortex
- Target Recruit Count
- 85
- Registration Number
- NCT04473963
- Locations
- 🇩🇪
Practice Clinic Heart And Vessels, Dresden, Saxony Land, Germany
🇩🇪University Heart and Vascular Center Hamburg, Hamburg, Germany
🇳🇱Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands
© Copyright 2025. All Rights Reserved by MedPath